Drugs for Alzheimer's disease.
作者信息
Ritter James M
出版信息
Br J Clin Pharmacol. 2012 Apr;73(4):501-3. doi: 10.1111/j.1365-2125.2012.04217.x.
Abstract
摘要
相似文献
1
Drugs for Alzheimer's disease.治疗阿尔茨海默病的药物。
Br J Clin Pharmacol. 2012 Apr;73(4):501-3. doi: 10.1111/j.1365-2125.2012.04217.x.
2
New drugs for Alzheimer's disease in Japan.日本治疗阿尔茨海默病的新药
Psychiatry Clin Neurosci. 2011 Aug;65(5):399-404. doi: 10.1111/j.1440-1819.2011.02253.x.
3
[Advances in Alzheimer's disease treatment].[阿尔茨海默病治疗的进展]
Rev Med Interne. 2006 Aug;27(8):585-7. doi: 10.1016/j.revmed.2006.05.001. Epub 2006 Jun 5.
4
UK government guidance on Alzheimer's drugs postponed.英国政府关于治疗阿尔茨海默病药物的指导意见被推迟。
Drug Discov Today. 2005 Sep 1;10(17):1132. doi: 10.1016/S1359-6446(05)03586-5.
5
Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.加兰他敏与美金刚联合治疗阿尔茨海默病的原理。
J Clin Pharmacol. 2006 Jul;46(7 Suppl 1):17S-26S. doi: 10.1177/0091270006288735.
6
Cholinesterase inhibitors and memantine have a role in the treatment of Alzheimer's disease.胆碱酯酶抑制剂和美金刚在阿尔茨海默病的治疗中发挥作用。
Nat Clin Pract Neurol. 2006 Nov;2(11):578-9. doi: 10.1038/ncpneuro0269.
7
[Pharmacological therapy in Alzheimer's disease. Current clinical practice in The Netherlands].[阿尔茨海默病的药物治疗。荷兰的当前临床实践]
Tijdschr Gerontol Geriatr. 2005 Jul;36(3):122-6.
8
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model.加兰他敏和美金刚在APP23模型中疾病修饰疗效的认知评估。
Eur Neuropsychopharmacol. 2006 Jan;16(1):59-69. doi: 10.1016/j.euroneuro.2005.06.005. Epub 2005 Aug 10.
9
Alzheimer's disease.阿尔茨海默病
N Engl J Med. 2004 Jul 1;351(1):56-67. doi: 10.1056/NEJMra040223.
10
Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study.美金刚与加兰他敏联合使用对阿尔茨海默病患者死亡率及疗效结局的影响：一项随机安慰剂对照研究的事后分析
Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.
引用本文的文献
1
A detailed biochemical characterization, toxicological assessment and molecular docking studies of : An important medicinal xero-halophyte.一种重要的药用旱生盐生植物的详细生化特性、毒理学评估及分子对接研究。
Saudi Pharm J. 2023 Jun;31(6):1047-1060. doi: 10.1016/j.jsps.2023.04.028. Epub 2023 May 6.
2
Chronic caffeine treatment reverses memory impairment and the expression of brain BNDF and TrkB in the PS1/APP double transgenic mouse model of Alzheimer's disease.慢性咖啡因处理可逆转 PS1/APP 双转基因阿尔茨海默病小鼠模型的记忆障碍和大脑 BDNF 和 TrkB 的表达。
Mol Med Rep. 2013 Sep;8(3):737-40. doi: 10.3892/mmr.2013.1601. Epub 2013 Jul 25.
本文引用的文献
1
New pharmacological strategies for treatment of Alzheimer's disease: focus on disease modifying drugs.治疗阿尔茨海默病的新药理学策略：关注疾病修饰药物。
Br J Clin Pharmacol. 2012 Apr;73(4):504-17. doi: 10.1111/j.1365-2125.2011.04134.x.
2
Vanishing clinical psychopharmacology.消失的临床精神药理学。
Br J Clin Pharmacol. 2011 Jul;72(1):1-5. doi: 10.1111/j.1365-2125.2011.04021.x.
3
Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial.长期锂治疗对遗忘型轻度认知障碍的疾病修饰作用：随机对照试验。
Br J Psychiatry. 2011 May;198(5):351-6. doi: 10.1192/bjp.bp.110.080044.
4
Current insights into molecular mechanisms of Alzheimer disease and their implications for therapeutic approaches.阿尔茨海默病分子机制的当前见解及其对治疗方法的影响。
Neurodegener Dis. 2007;4(5):349-65. doi: 10.1159/000105156. Epub 2007 Jul 6.
5
Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain.唐氏综合征和正常大脑中α-和β-分泌酶活性与年龄及β-淀粉样蛋白的关系
Neurobiol Aging. 2007 Oct;28(10):1493-506. doi: 10.1016/j.neurobiolaging.2006.06.023. Epub 2006 Aug 9.
6
Alzheimer disease and Down syndrome: factors in pathogenesis.阿尔茨海默病与唐氏综合征：发病机制中的因素
Neurobiol Aging. 2005 Mar;26(3):383-9. doi: 10.1016/j.neurobiolaging.2004.08.005.
7
Acetylcholinesterase inhibitors in Alzheimer's disease.用于治疗阿尔茨海默病的乙酰胆碱酯酶抑制剂
Br J Clin Pharmacol. 1999 Oct;48(4):471-80. doi: 10.1046/j.1365-2125.1999.00026.x.
8
Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice.转基因小鼠中的相关记忆缺陷、β-淀粉样蛋白升高和淀粉样斑块。
Science. 1996 Oct 4;274(5284):99-102. doi: 10.1126/science.274.5284.99.
9
Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F beta-amyloid precursor protein and Alzheimer's disease.过表达V717Fβ-淀粉样前体蛋白的转基因小鼠与阿尔茨海默病神经退行性病理学比较
J Neurosci. 1996 Sep 15;16(18):5795-811. doi: 10.1523/JNEUROSCI.16-18-05795.1996.
10
Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.载脂蛋白E4等位基因的基因剂量与晚发型家族性阿尔茨海默病的风险
Science. 1993 Aug 13;261(5123):921-3. doi: 10.1126/science.8346443.
Zotero 插件